Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa

被引:63
作者
McCutchan, FE
Artenstein, AW
SandersBuell, E
Salminen, MO
Carr, JK
Mascola, JR
Yu, XF
Nelson, KE
Khamboonruang, C
Schmitt, D
Kieny, MP
McNeil, JG
Burke, DS
机构
[1] WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,WASHINGTON,DC 20307
[2] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD
[3] CHIANG MAI UNIV,CHIANG MAI 50000,THAILAND
[4] TRANSGENE SA,STRASBOURG,FRANCE
关键词
D O I
10.1128/JVI.70.6.3331-3338.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 isolates of clade E, known to be largely responsible for the fulminating epidemic in Southeast Asia, have been derived exclusively from Asia and Africa. Here,ve provide full or partial sequences of the envelope glycoprotein gene from 13 additional clade E isolates from Asia representing patients in both early and late stages of disease. More extensive comparison of isolates within clade E by geographic locale, stage of disease, and year of isolation is now possible. The genetic diversity of clade E isolates from Asia, particularly among those derived from early-stage patients, is restricted compared with African isolates (mean interisolate distances in gp120, 5.4 and 20.2%, respectively). However, patients hospitalized with AIDS-related illnesses in Thailand harbored clade E isolates exhibiting broader interisolate diversity and with highly heterogeneous third hypervariable loop sequences. An additional pair of cysteine residues, predicting a novel disulfide bridge and present in 80% of clade E isolates from Asia, was uniformly absent from six African isolates. Clade E isolates in Thailand from early-stage subjects continue to be genetically similar to potential vaccine prototype strains, providing a favorable environment for the evaluation of genotype E candidate vaccines. However, evidence of increasing interisolate diversity is appearing among late-stage patients in Asia. This diversification of the clade E virus, if sustained, may impact preventive vaccine development strategies.
引用
收藏
页码:3331 / 3338
页数:8
相关论文
共 44 条
[1]  
ARDMAN B, 1990, J ACQ IMMUN DEF SYND, V3, P206
[2]   MULTIPLE INTRODUCTIONS OF HIV-1 SUBTYPE-E INTO THE WESTERN-HEMISPHERE [J].
ARTENSTEIN, AW ;
COPPOLA, J ;
BROWN, AE ;
CARR, JK ;
SANDERSBUELL, E ;
GALBARINI, E ;
MASCOLA, JR ;
VANCOTT, TC ;
SCHONBROOD, P ;
MCCUTCHAN, FE ;
BURKE, DS .
LANCET, 1995, 346 (8984) :1197-1198
[3]   DUAL INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 OF DISTINCT ENVELOPE SUBTYPES IN HUMANS [J].
ARTENSTEIN, AW ;
VANCOTT, TC ;
MASCOLA, JR ;
CARR, JK ;
HEGERICH, PA ;
GAYWEE, J ;
SANDERSBUELL, E ;
ROBB, ML ;
DAYHOFF, DE ;
THITIVICHIANLERT, S ;
NITAYAPHAN, S ;
MCNEIL, JG ;
BIRX, DL ;
MICHAEL, RA ;
BURKE, DS ;
MCCUTCHAN, FE .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :805-810
[4]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[5]   DETECTION OF DIVERSE HIV-1 GENETIC SUBTYPES IN THE USA [J].
BRODINE, SK ;
MASCOLA, JR ;
WEISS, PJ ;
ITO, SI ;
PORTER, KR ;
ARTENSTEIN, AW ;
GARLAND, FC ;
MCCUTCHAN, FE ;
BURKE, DS .
LANCET, 1995, 346 (8984) :1198-1199
[6]  
BURKE DS, 1990, J ACQ IMMUN DEF SYND, V3, P1159
[7]  
BURKE DS, 1996, AIDS ETIOLOGY DIAGNO
[8]   SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING CAPACITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUBTYPES OTHER THAN B - PHENOTYPIC AND GENOTYPIC CHARACTERISTICS [J].
DEWOLF, F ;
HOGERVORST, E ;
GOUDSMIT, J ;
FENYO, EM ;
RUBSAMENWAIGMANN, H ;
HOLMES, H ;
GALVAOCASTRO, B ;
KARITA, E ;
WASI, C ;
SEMPALA, SDK ;
BAAN, E ;
ZORGDRAGER, F ;
LUKASHOV, V ;
OSMANOV, S ;
KUIKEN, C ;
CORNELISSEN, M ;
BELSEY, EM ;
HEYWARD, W ;
ESPARZA, J ;
VANDEPERRE, P ;
SEMPALA, S ;
TUGUME, B ;
BIRYAHWAHO, B ;
VONBRIESEN, H ;
ESSER, R ;
GREZ, M ;
NEWBERRY, A ;
RANJBAR, S ;
TOMLINSON, P ;
BRADAC, J ;
MCCUTCHAN, F ;
LOUWAGIE, J ;
HEGERICH, P ;
LOPEZGALINDEZ, C ;
OLIVARES, I ;
DOPAZO, J ;
MULLINS, JI ;
DELWART, EL ;
BACHMANN, HM ;
HAHN, BH ;
GAO, F ;
YUE, L ;
SARAGOSTI, S ;
SCHOCHETMAN, G ;
KALISH, M ;
LUO, CC ;
GEORGE, R ;
PAU, CP ;
WEBER, J ;
CHEINGSONGPOPOV, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1387-1400
[9]   THE DEVELOPMENT AND EVALUATION OF HIV VACCINES [J].
ESPARZA, J ;
OSMANOV, S .
CURRENT OPINION IN INFECTIOUS DISEASES, 1993, 6 (02) :218-229
[10]   HUMAN TRIALS OF EXPERIMENTAL AIDS VACCINES [J].
FAST, PE ;
WALKER, MC .
AIDS, 1993, 7 :S147-S159